Swiss National Bank Has $97,346,000 Stake in Cigna Corp. (CI)
Swiss National Bank reduced its position in Cigna Corp. (NYSE:CI) by 0.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 746,974 shares of the company’s stock after selling 6,900 shares during the period. Swiss National Bank owned approximately 0.29% of Cigna Corp. worth $97,346,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Marco Investment Management LLC raised its position in Cigna Corp. by 0.6% in the second quarter. Marco Investment Management LLC now owns 1,585 shares of the company’s stock worth $203,000 after buying an additional 10 shares during the period. Private Trust Co. NA raised its position in Cigna Corp. by 0.7% in the third quarter. Private Trust Co. NA now owns 1,702 shares of the company’s stock worth $221,000 after buying an additional 11 shares during the period. Checchi Capital Advisers LLC raised its position in Cigna Corp. by 0.7% in the second quarter. Checchi Capital Advisers LLC now owns 2,624 shares of the company’s stock worth $336,000 after buying an additional 17 shares during the period. OLD National Bancorp IN raised its position in Cigna Corp. by 0.3% in the third quarter. OLD National Bancorp IN now owns 5,955 shares of the company’s stock worth $776,000 after buying an additional 19 shares during the period. Finally, Synovus Financial Corp raised its position in Cigna Corp. by 0.7% in the second quarter. Synovus Financial Corp now owns 3,285 shares of the company’s stock worth $420,000 after buying an additional 24 shares during the period. Institutional investors and hedge funds own 84.62% of the company’s stock.
Cigna Corp. (NYSE:CI) opened at 136.77 on Tuesday. Cigna Corp. has a 12-month low of $115.03 and a 12-month high of $148.99. The stock has a market capitalization of $35.11 billion, a P/E ratio of 18.59 and a beta of 0.50. The firm’s 50-day moving average price is $128.01 and its 200 day moving average price is $129.25.
Cigna Corp. (NYSE:CI) last issued its earnings results on Thursday, November 3rd. The company reported $1.94 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.91 by $0.03. The business had revenue of $9.90 billion for the quarter, compared to analysts’ expectations of $4.37 billion. Cigna Corp. had a return on equity of 16.17% and a net margin of 4.87%. The business’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.28 EPS. On average, equities analysts anticipate that Cigna Corp. will post $7.98 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Swiss National Bank Has $97,346,000 Stake in Cigna Corp. (CI)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of US & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/29/swiss-national-bank-has-97346000-stake-in-cigna-corp-ci.html.
CI has been the subject of a number of research reports. Goldman Sachs Group Inc. reissued a “buy” rating and set a $160.00 price target on shares of Cigna Corp. in a research note on Thursday, September 8th. Leerink Swann dropped their price target on Cigna Corp. from $160.00 to $155.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Zacks Investment Research raised Cigna Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, October 4th. William Blair reaffirmed a “buy” rating on shares of Cigna Corp. in a research note on Wednesday, August 31st. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Cigna Corp. in a research note on Tuesday, August 23rd. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Cigna Corp. presently has a consensus rating of “Buy” and an average price target of $156.00.
In related news, EVP John M. Murabito sold 58,822 shares of the company’s stock in a transaction that occurred on Monday, November 7th. The stock was sold at an average price of $125.09, for a total value of $7,358,043.98. Following the transaction, the executive vice president now directly owns 115,109 shares in the company, valued at $14,398,984.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jason D. Sadler sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, October 31st. The shares were sold at an average price of $121.80, for a total value of $487,200.00. Following the completion of the transaction, the insider now owns 34,019 shares in the company, valued at $4,143,514.20. The disclosure for this sale can be found here. Insiders own 1.20% of the company’s stock.
Cigna Corp. Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.
Receive News & Stock Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related stocks with our FREE daily email newsletter.